Kingdom of Norway contributes NOK 600 million to IFFIm

New donation will back Vaccine Bonds to fund CEPI’s fight against deadly diseases

THIS DOCUMENT IS NOT AN OFFER FOR THE SALE OF SECURITIES. THIS DOCUMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY, THE UNITED STATES.

India 2007

Credit: Gavi/2007/Atul Loke.

Geneva, 29 May 2019 – The Kingdom of Norway has agreed to donate NOK 600 million to the International Finance Facility for Immunisation (IFFIm). The donation is intended to support the Coalition for Epidemic Preparedness Innovation (CEPI). In a novel arrangement approved by Gavi, the Vaccine Alliance, IFFIm is planning to issue bonds on international capital markets, backed by the donation from Norway, which hosts CEPI.

CEPI, which is developing new vaccines for some of the world’s most dangerous infectious diseases, is an innovative partnership between public, private, philanthropic, and civil organisations launched in Davos in January 2017. CEPI’s immediate mandate is to develop vaccines for six diseases with outbreak potential: Nipah Virus, Lassa Fever, Disease X, Rift Valley fever, Chikungunya and Middle East Respiratory Syndrome (MERS). CEPI is coordinating the development of these new vaccines and will eventually make them available at affordable prices to low-income countries disproportionately affected by these epidemics.

Read the full press release on the Gavi website. [Version française] 

close icon

modal window here